Dr. Adi R. Nir brings 15 years of diversified healthcare experience consisting of both academic research and operational practice. Adi specializes in health economics, market evaluation and financial valuation of pharmaceuticals assets, medical devices and digital health products.
Adi provides companies strategic tools for the development and implementation of the product’s value story, via tools of health economics and product valuation, used by companies for reimbursement or licensing purposes.
In her previous positions, Adi has held several BD and product management positions at Dexcel, Lumenis , BiolineRx and Maccabi Health care. She has done both in and out licensing, strategic planning of global marketing and negotiations. She has been responsible for multiple comprehensive due diligence processes, including scientific, clinical and commercial evaluations as well as financial valuations of licensing opportunities of innovative assets.
Mrs. Nir holds a PhD in Health Economics, MSc. in Molecular Biology, and MBA from the Hebrew University.